The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Shore Says Buy Shire, Hold GlaxoSmithKline

Wed, 25th May 2016 08:34

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
GOLDMAN RAISES COMPASS GROUP TO 'NEUTRAL' ('SELL') - TARGET 1269 (1020) PENCE
----------
EXANE BNP RAISES SEVERN TRENT TARGET TO 2050 (1900) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES VODAFONE PRICE TARGET TO 300 (295) PENCE - 'BUY'
----------
Investec Cuts Barclays To Hold From Buy, Keeps Target At 195p
----------
MACQUARIE RAISES SCHRODERS PRICE TARGET TO 2400 (2300) PENCE - 'NEUTRAL'
----------
UBS CUTS CAPITA GROUP PRICE TARGET TO 1125 (1200) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES RIO TINTO PRICE TARGET TO 2600 (2300) PENCE - 'OVERWEIGHT'
----------
SHORE CAPITAL INITIATES GLAXOSMITHKLINE WITH 'HOLD' - TARGET 1500 PENCE
----------
SHORE CAPITAL INITIATES SHIRE WITH 'BUY' - TARGET 5600 PENCE
----------
MACQUARIE CUTS BT GROUP PRICE TARGET TO 360 (375) PENCE - 'UNDERPERFORM'
----------
FTSE 250
----------
JPMORGAN CUTS ENTERTAINMENT ONE PRICE TARGET TO 214 (217) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOMESERVE PRICE TARGET TO 426 (415) PENCE - 'NEUTRAL'
----------
Liberum Lifts Homeserve Target To 550p From 500p, Keeps Buy
----------
JEFFERIES RAISES BIG YELLOW GROUP PRICE TARGET TO 825 (725) PENCE - 'HOLD'
----------
JPMORGAN CUTS STAGECOACH TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 256 (338) PENCE
----------
JPMORGAN RAISES NATIONAL EXPRESS TO OVERWEIGHT (NEUTRAL) - TARGET 362 (335) P.
----------
MACQUARIE RAISES JUPITER FUND PRICE TARGET TO 400 (380) PENCE - 'NEUTRAL'
----------
HSBC RAISES MITCHELLS & BUTLERS TO 'BUY' ('HOLD') - TARGET 340 (300) PENCE
----------
HSBC RAISES HALFORDS GROUP PRICE TARGET TO 490 (470) PENCE - 'BUY'
----------
Liberum Ups AVEVA Group Target To 1,500p From 1,450p, Keeps Hold
----------
BARCLAYS CUTS AVEVA GROUP PRICE TARGET TO 1450 (1530) PENCE - 'EQUAL WEIGHT'
----------
GOLDMAN RAISES AVEVA GROUP PRICE TARGET TO 1350 (1300) PENCE - 'SELL'
----------
BARCLAYS CUTS SHAWBROOK PRICE TARGET TO 340 (375) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS UBM PRICE TARGET TO 667 (695) PENCE - 'BUY'
----------
GOLDMAN CUTS DAIRY CREST GROUP PRICE TARGET TO 545 (550) PENCE - 'SELL'
----------
SHORE CAPITAL RAISES RATHBONE BROS TO 'BUY' ('HOLD') - TARGET 1940 PENCE
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES DE LA RUE PRICE TARGET TO 530 (500) PENCE - 'NEUTRAL'
----------
BERENBERG RAISES SCAPA GROUP PRICE TARGET TO 310 (300) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.